GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vytrus Biotech SA (XMAD:VYT) » Definitions » Price-to-Free-Cash-Flow

Vytrus Biotech (XMAD:VYT) Price-to-Free-Cash-Flow : 68.09 (As of May. 27, 2025)


View and export this data going back to 2022. Start your Free Trial

What is Vytrus Biotech Price-to-Free-Cash-Flow?

As of today (2025-05-27), Vytrus Biotech's share price is €3.20. Vytrus Biotech's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2024 was €0.05. Hence, Vytrus Biotech's Price-to-Free-Cash-Flow Ratio for today is 68.09.

The historical rank and industry rank for Vytrus Biotech's Price-to-Free-Cash-Flow or its related term are showing as below:

XMAD:VYT' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 65.96   Med: 132   Max: 152
Current: 65.96

During the past 6 years, Vytrus Biotech's highest Price-to-Free-Cash-Flow Ratio was 152.00. The lowest was 65.96. And the median was 132.00.

XMAD:VYT's Price-to-Free-Cash-Flow is ranked worse than
74.12% of 228 companies
in the Biotechnology industry
Industry Median: 30.63 vs XMAD:VYT: 65.96

Vytrus Biotech's Free Cash Flow per Share for the six months ended in Jun. 2024 was €0.00. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was €0.05.


Vytrus Biotech Price-to-Free-Cash-Flow Historical Data

The historical data trend for Vytrus Biotech's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vytrus Biotech Price-to-Free-Cash-Flow Chart

Vytrus Biotech Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial - - - - -

Vytrus Biotech Semi-Annual Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Vytrus Biotech's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, Vytrus Biotech's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vytrus Biotech's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vytrus Biotech's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Vytrus Biotech's Price-to-Free-Cash-Flow falls into.


;
;

Vytrus Biotech Price-to-Free-Cash-Flow Calculation

Vytrus Biotech's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=3.20/0.047
=68.09

Vytrus Biotech's Share Price of today is €3.20.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Vytrus Biotech's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2024 was €0.05.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Vytrus Biotech  (XMAD:VYT) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Vytrus Biotech Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Vytrus Biotech's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Vytrus Biotech Business Description

Traded in Other Exchanges
N/A
Address
Sant Gaieta 121, 2nd, Terrassa, Barcelona, ESP, 08221
Vytrus Biotech SA develops natural active ingredients on an industrial scale. The natural actives offered by the company include Nectaria Lithops, Olea Vitae, Turmeric zen, Capilia Longa, Qura Noni.

Vytrus Biotech Headlines

No Headlines